Advanced Medicine

The pipeline of early-stage CRISPR therapeutics is huge, but advancing these innovations will require a multifaceted strategy.

The science of oligonucleotides is advancing, but advanced manufacturing techniques are needed to optimize their impact

How digital technology has, and will continue to, augment scientific data collection and discovery

Developing science is good; developing successful commercialization strategies is great.

Cell therapy has come a long way since the 1930s. Next, we need to find a way to bring the costs down by using allogeneic approaches.

Jason Bock highlights the need for innovative manufacturing solutions and supply chain improvements in cell therapy.

Why cell and gene therapy manufacturing has a lot to learn from the automotive sector.

Experts discuss the trends, challenges, and possibilities of cryopreservation for cell and gene – and how it can freeze time in manufacturing.

Experts from Lonza share how biologics and CGT can recognize the gaps and similarities that can be utilized to optimize cell culture media challenges.

The Nobel Prize for Medicine has again been awarded jointly, this time for miRNA discovery and its role in gene regulation